Autologous stem cell transplantation in elderly lymphoma patients in their 70s: outcomes and analysis

Autologous stem cell transplantation in elderly lymphoma patients in their 70s: outcomes and analysis is organized by Society for Translational Oncology (STO).

Released: 6/4/2018
Expires: 6/4/2020

Target Audience:
Physicians who wish to advance their current knowledge of hematological malignancies.

Accreditation and Credit Designation:
The Society for Translational Oncology is accredited by the ACCME to provide continuing medical education for physicians.

The Society for Translational Oncology designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Learning Objectives:
• Discuss the safety and feasibility of ASCT in elderly lymphoma patients.
• Discuss the tools needed to evaluate the impact of comorbid conditions for risk of non-relapse mortality in elderly ASCT recipients.

Additional details will be posted as soon as they are available.